China Oncology

Loading...

Welcome to China Oncology,

China Oncology

30 October 2019, Volume 29 Issue 10 Previous Issue Next Issue

Cover and contents

2019 Issue 10 Cover

Abstract ( 454) PDF (889KB) ( 726 )

Contents of Issue 10, 2019

Abstract ( 107) PDF (236KB) ( 708 )

The timing of surgery during neoadjuvant therapy for breast cancer

MAO Yan, WANG Haibo

2019, 29 (10): 761-766. doi: 10.19401/j.cnki.1007-3639.2019.10.001

Abstract ( 942) PDF (1124KB) ( 2536 )

Experimental study on quinacrine inducing apoptosis in extranodal natural killer (NK)/T-cell lymphoma cells

YANG Xue,WU Yingli,XU Jie,TONG Jia,JING Bo,WANG Yingying,ZHU Qi

2019, 29 (10): 767-772. doi: 10.19401/j.cnki.1007-3639.2019.10.002

Abstract ( 581) PDF (1651KB) ( 1552 )

Correlation between cancer cell stemness and glucose metabolism characteristics in hepatocellular carcinoma

LI Yihao, DAI Qian, WANG Beili, PAN Baishen, GUO Wei

2019, 29 (10): 773-779. doi: 10.19401/j.cnki.1007-3639.2019.10.003

Abstract ( 791) PDF (1789KB) ( 1772 )

Screening of aberrant DNA methylation in papillary thyroid cancer

CAO Yiming, ZHU Yongxue

2019, 29 (10): 780-787. doi: 10.19401/j.cnki.1007-3639.2019.10.004

Abstract ( 692) PDF (1334KB) ( 1494 )

The effect of miR-27a-3p on chemotherapy sensitivity in hepatocellular carcinoma cells and its mechanism

YANG Ying, YANG Zhifang, CAI Ceng, ZHANG Ruili, LU Pengfei, JIA Chunli, LI Zhipeng, MAO Rui, ZHANG Hua, BAO Yongxing

2019, 29 (10): 788-794. doi: 10.19401/j.cnki.1007-3639.2019.10.005

Abstract ( 752) PDF (3935KB) ( 1663 )

The influence of PD-L1 rs2297136 polymorphism on the clinical outcomes of postoperative colorectal cancer patients receiving capecitabine-based adjuvant chemotherapy

ZHANG Huijian,LIU Dianwen,ZHOU Xiaoli,LIU Yonggang,LI Min,LIU Shiju

2019, 29 (10): 795-802. doi: 10.19401/j.cnki.1007-3639.2019.10.006

Abstract ( 621) PDF (1291KB) ( 1753 )

The single-center analysis of the efficacy and safety of nivolumab monoclonal antibody in advanced non-small cell lung cancer

LI Jingwen, ZHOU Yan, CAO Shuhui, WANG Yue, ZHONG Hua

2019, 29 (10): 803-808. doi: 10.19401/j.cnki.1007-3639.2019.10.007

Abstract ( 783) PDF (1393KB) ( 1314 )

Clinical efficacy of osimertinib in the treatment of 62 patients with advanced lung adenocarcinoma

GAO Zhiqiang,WANG Weimin,CAI Yuqing,QIN Ruoyan,GU Aiqin,XIONG Liwen,HAN Baohui,JIANG Liyan,SHI Chunlei

2019, 29 (10): 809-814. doi: 10.19401/j.cnki.1007-3639.2019.10.008

Abstract ( 838) PDF (1105KB) ( 2235 )

Application of radiomics signature captured from CT to predicting brain metastases in stage Ⅲ/Ⅳ anaplastic lymphoma kinase-positive non-small cell lung cancer patients

XU Xinyan, CHEN Jiayan, HUANG Lü, WANG Jiazhou, LIU Di,WEN Junmiao, CAO Jianzhao, FAN Min

2019, 29 (10): 815-823. doi: 10.19401/j.cnki.1007-3639.2019.10.009

Abstract ( 966) PDF (1605KB) ( 1673 )

Advances in molecular targeted therapies for soft tissue sarcomas

LUO Chunli, LI Zhiping

2019, 29 (10): 824-831. doi: 10.19401/j.cnki.1007-3639.2019.10.010

Abstract ( 777) PDF (1104KB) ( 2860 )

中国癌症杂志

Database Indexing

A Guide to the Core Journals of China
Chinese Science Citation Database (CSCD)
China National Knowledge Infrastructure (CNKI)
Chinese Sci-tech Paper and Citation Database (CSTPCD)
Outsanding S&T Journals of China (2020) (F5000)
World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
SCOPUS
EMBASE
DOAJ
Chemical Abstracts (CA)
Japan Science and Technology Database (JST)
The Western Pacific Region Index Medicus (WPRIM)
EBSCO
Index of Copernicus International (ICI)

Competent Authorities

　The Ministry of Education of the People’s Republic of China

Sponsored by

　Fudan University Shanghai Cancer Center

Edited by

　Editorial Board of China Oncology

Editor-in-Chief

　SHAO Zhimin

Honorary Editor-in-Chief

　TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

　Shanghai Ouyang Printing Co., Ltd.

WeChat